Activation of Myc triggers a rapid induction of cyclin E/ cdk2 kinase activity and degradation of p27. Overt degradation of p27 is preceded by a speci®c dissociation of p27 from cyclin E/cdk2, but not from cyclin D/cdk4 complexes. We now show that cyclin E/cdk2 phosphorylates p27 at a carboxy-terminal threonine residue (T187) in vitro; mutation of this residue to valine stabilises cyclin E/cdk2 complexes. This reaction is not signi®cantly inhibited by high concentrations of p27, suggesting that cdk2 bound to p27 is catalytically active. In vivo, p27 bound to cyclins E and A, but not to D-type cyclins is phosphorylated. Myc-induced release of p27 from cdk2 requires cdk2 kinase activity and is delayed in a T187V mutant of p27. After induction of Myc, p27 phosphorylated at threonine 187 transiently accumulates in a non cdk2 bound form. Our data suggest a mechanism in which p27 is released from cyclin E/cdk2 upon phosphorylation; in Myc-transformed cells, release is ecient as phosphorylated p27 is transiently bound in a non-cdk2 containing complex and subsequently degraded.
Introduction
The proto-oncogene c-myc encodes a helix ± loop ± helix/leucine zipper protein (Myc) that activates genes as part of a heterodimeric complex with a partner protein termed Max (for recent reviews, see Bernards, 1995; Henriksson and LuÈ scher, 1996) . Myc/Max complexes bind to speci®c DNA sequences with a central CAC(G/A)TG motif (Blackwell et al., 1993; Prendergast and Zi, 1991) . They activate transcription due to potent transactivation domains localized in the amino-terminus of Myc (Desbarats et al., 1996; Kato et al., 1990) . Several genes that are regulated by Myc/ Max complexes in vivo have been isolated (BelloFernandez et al., 1993; Eilers et al., 1991; Galaktionov et al., 1996; Grandori et al., 1996; Miltenberger et al., 1995) . In quiescent cells, in which c-myc is usually not expressed, Max homodimers accumulate, which bind to the same sequence yet fail to activate transcription (Kao et al., 1992) . Other proteins, termed Mad, Mxi and Mnt, have been identi®ed that bind to Max, but not Myc Hurlin et al., 1995 Hurlin et al., , 1997 Zervos et al., 1993) . They often accumulate during cellular dierentiation . Mad/Max and Mxi/Max recognize the same DNA element as Myc/Max complexes, but act as transcriptional repressors via recruitment of a co-repressor protein termed sin3 (e.g. Ayer et al., 1995; Laherty et al., 1997; Rao et al., 1996; Schreiber Agus et al., 1995; Sommer et al., 1997) . Ectopic expression of c-myc also induces loss of expression of a number of genes and this may not be mediated via complex formation with Max (Peukert et al., 1997; Philipp et al., 1994; Roy et al., 1993; Shrivastava et al., 1993) .
c-myc is a central regulator of both proliferation and apoptosis in mammalian and avian cells. For example, constitutive expression of Myc or activation of conditional alleles (MycER) in culture disrupts the growth factor dependence of cell cycle progression observed in normal cells (Eilers et al., 1991; Evan et al., 1992; Keath et al., 1984) . Transgenic animals, in which c-myc is expressed under the control of an IgHenhancer, display a distinct preneoplastic phenotype which is characterized by an enhanced rate of proliferation and an increase in the number of preB cells (Langdon et al., 1986) . Ectopic expression of Mad-1 protein blocks CSF-1 induced mitogenesis, demonstrating an essential role for Myc proteins in G1 progression (Roussel et al., 1996) ; this is supported by experiments using antisense oligonucleotides to inhibit expression of Myc (Heikkila et al., 1987; Prochownik et al., 1988) . Also, knock-out animals in which the c-myc gene has been disrupted, die early in embryogenesis (Davis et al., 1993) .
A number of observations show that Myc exerts its eect on cellular proliferation at least in part through activation of cyclin E/cdk2 kinase activity. First, induction of conditional alleles of Myc in RAT1-MycER cells leads to a rapid induction of cyclin E/ cdk2 kinase activity, which precedes any overt change in cellular proliferation (Steiner et al., 1995) . Myc upregulates cyclin E/cdk2 kinase activity not only during the G0/G1 transition, but also disrupts the cell cycle dependent regulation of cyclin E/cdk2 kinase activity normally observed in exponentially proliferating cells (Pusch et al., 1997) . Thus, activation of Myc leads to strongly elevated levels of cyclin E/cdk2 activity very early in the G1 phase of the cell cycle. Second, dominant negative alleles of Myc inhibit cyclin E/cdk2 kinase activity in exponentially growing cells (Berns et al., 1997) . Third, activation of cyclin E/cdk2 kinase is required for mitogenic responses to activated Myc and is at least in part sucient to account for them: for example, activation of cyclin A gene expression by Myc is mediated by cyclin E/cdk2 kinase (Rudolph et al., 1996) . Fourth, expressing of cdc25A, a phosphatase thought to be involved in Human cyclin E protein levels and associated kinase activity in con¯uent RAT1-MycER (hcE) cells before (7) and 12 h after (+) activation of Myc. (b) Release from p27 is required for activation of human cyclin E/cdk2 by Myc. Upper panel: Anti-human cyclin E Western blot documenting the speci®c association of human cyclin E with p27 in resting RAT1-MycER(hcE) cells). Lower panel: Immune complex kinase assays before (`74-OHT') or after activation of Myc (`+4-OHT') with either anti-human cyclin E antibodies or two dierent anti-p27 antibodies as indicated. (c) Human cyclin E/cdk2 complexes isolated from Myc-induced cells can be activated by treatment with cdc25A in vitro. Anti-human cyclin E immunepricipates from either uninduced RAT1-MycER(hcE) cells (7) or from cells incubated for 12 h with 200 nM 4-OHT (+) were treated with recombinant cdc25A in vitro as described previously (Steiner et al., 1995) . Complexes were reisolated and histone H1 kinase activity determined. The panel shows the speci®c histone H1 activity in untreated samples (`basal') and the additional kinase activity released by treatment with cdc25A (`latent'). Cells labelled 4-OHT/PSI were incubated for 12 h with 4-OHT in the presence of the proteasome inhibitor, PSI (see Figure 2) activation of cyclin E/cdk2, is upregulated by Myc via an E-box element in the second intron of the gene (Galaktionov et al., 1996) In resting RAT1-MycER ®broblasts, cyclin E/cdk2 kinase is inactive despite the presence of considerable amounts of cyclin E, cdk2 and cdc25A proteins and of assembled cyclin E/cdk2 complexes (Perez-Roger et al., 1997; Steiner et al., 1995) . In a pulse-chase experiment, activation of Myc induced a shift of pre-formed high molecular cyclin E/cdk2 complexes to a lower molecular weight, suggesting that induction of Myc might lead to the activation of pre-existing cdk2 complexes. Recent experiments demonstrated that Myc antagonises growth suppression by low amounts of p27, suggesting that it may direct the synthesis of IP: co E co E co E time (hrs) a b IP: co p27 co p27 co p27
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IP: co ck2 co ck2 co ck2 proteins that can bind to and sequester p27 (Vlach et al., 1996) . We now show that activation of cyclin E/ cdk2 kinase by Myc in resting RAT1 ®broblasts occurs by a similar mechanism. Further, we show that p27 is ®rst selectively lost from cdk2 complexes, but not from cyclin D/cdk4 complexes after activation of Myc and show that this speci®city is due to phosphorylation of p27 by cdk2 at a carboxy-terminal threonine residue. Finally, we show that binding of p27 does not abolish the catalytic activity of cdk2 towards p27; taken together the data suggest a simple model as to how the speci®c activation of cyclin E/cdk2 kinase activity upon activation by Myc may be achieved.
Results
Previous work had shown that activation of Myc triggers a rapid induction of cyclin E/cdk2 kinase activity in resting RAT1-MycER ®broblasts; this activation occurred despite the presence of considerable amounts of cyclin E protein and of assembled cyclin E/cdk2 complexes in arrested RAT1-MycER ®broblasts (Steiner et al., 1995) . To facilitate the analysis of this process, we generated a cell line that expressed human cyclin E constitutively from a retroviral promoter (RAT1-MycER(hcE); Figure 1a ). Western blotting with monoclonal antibodies directed against human cyclin E detected the protein speci®cally in transfected cells, but not in lysates from control cells and no crossreaction with rodent cyclin E was observed ( Figure 1a ). To test whether induction of Myc aected the kinase activity associated with human cyclin E, cells were grown to con¯uence and arrested for several days. Subsequently, MycER chimeras were activated by addition of 200 nM hydroxy-tamoxifen (4-OHT) and lysates prepared twelve hours later. Addition of 4-OHT did not enhance expression levels of human cyclin E protein ( Figure 1a ). Indeed, a moderate decrease in the amount of human cyclin E protein relative to control cells was observed, which was due to degradation of cyclin E (see Figure 2 ) (Clurman et al., 1996; Won and Reed, 1996) . No kinase activity associated with human cyclin E could be detected in resting cells, whereas stimulated cells showed a high cyclin E speci®c kinase activity ( Figure 1a) . Thus, the constitutively expressed human cyclin E closely mimics the behaviour of the endogenous cyclin E gene under these experimental conditions. Immune-precipitations revealed that human cyclin E was associated with p27 in resting cells (Figure 1b) . By Western blotting, neither p21 nor p57 could be detected in extracts from RAT1 cells; this is supported by depletion experiments showing that p27 accounts for most of the inhibitory activity present in heattreated lysates from RAT1-MycER cells (data not shown). To test whether release from p27 was required for induction of human cyclin E/cdk2, immuneprecipitations were carried out with either antibodies directed against human cyclin E or two dierent antisera directed against p27. As reported above, Myc strongly upregulated human cyclin E-associated kinase activity. At no point did we detect any histone H1 kinase activity associated with p27 (Figure 1b) , despite the fact that anti-p27 immune-precipitates contained signi®cant amounts of both cdk2 and cyclin E (see Figure 2) . We concluded from this experiment that only the fraction of cyclin E/cdk2 that had lost p27 became catalytically active upon induction of Myc. Thus release from p27 is required for activation of human cyclin E/cdk2 kinase by Myc in RAT1-MycER cells.
Recently, cdc25A, a phosphatase involved in the regulation of cdk2 kinase activity, has been shown to be a target for transcriptional induction by Myc (Galaktionov et al., 1996) . To determine whether complexes formed with human cyclin E were dephosphorylated at threonine-14 or tyrosine-15, we treated human cyclin E/cdk2 complexes from induced cells and non-induced cells with recombinant cdc25A in vitro. From these data, we calculated that more than 70% of human cyclin E/cdk2 complexes present after induction of Myc were still inhibited by phosphorylation of cdk2 at either threonine-14, tyrosine-15 or both, suggesting that cdc25A remains limiting for full activation of human cyclin E/cdk2 complexes ( Figure 1c) ; this is similar to ®ndings for the endogenous cyclin E gene (Steiner et al., 1995) . The amount of cdc25A protein is not aected by activation of MycER in RAT1 ®broblasts under conditions where ecient induction of cyclin E/cdk2 kinase occurs (Perez-Roger et al., 1997; Pusch et al., 1997; Vlach et al., 1996) ; and cdc25A protein is detectable in resting RAT1-MycER cells (Perez-Roger et al., 1997) . Thus, no evidence could be obtained that changes in the amount of cdc25A protein are involved in activation of cyclin E/ cdk2 kinase by MycER in this particular cell line. Anti-p27 Western blot of an isoelectric-focusing-2D gel of anti-cdk2, anti-cyclin D2, anti-cyclin A, and anti-cyclin E immune-precipitates from mouse telencephalic vesicles. Anti-cyclin E and cyclin A immune-precipitates were analysed by¯uoroimager after Western blotting for enhanced sensitivity, the remainder by exposure to ®lm Myc does not aect the expression of p27 mRNA in RAT1-MycER cells (Steiner et al., 1995) . During the G1/S-transition, levels of p27 protein have been reported to be regulated by two distinct mechanisms: ®rst, translation of p27 is regulated in HeLa cells (Hengst and Reed, 1996) and, second, p27 is degraded in a proteasome-dependent manner . To test which of both, if any modulates protein levels of p27 in RAT1-MycER cells after induction of Myc, 4-OHT was added to RAT1-MycER cells either alone or together with a speci®c inhibitor of proteasome function (PSI: Figueiredo Pereira et al., 1994; Traenckner et al., 1995) or of ICE proteases (ICE inhibitor I, Bachem: An and Knox, 1996; Jacobsen et al., 1996) as a control. In the presence of PSI, but not in the presence of ICE inhibitor, p27 protein levels were unaected by Myc (Figure 2a ). We concluded that induction of Myc stimulates proteasome-mediated degradation of p27.
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: 5 50 500 5 50 500 50 500 --5 50 500 --5 50 500 cyclin E histone H1 p27 nM 100 500 100 500 100 500 100 500 100 500 2500 cyclin E histone H1 p27 wt S10A T187V T187E p27∆ H1 a b c wt S10A T187V T187V p27∆ T187E Figure 5 In vitro phosphorylation of p27 by cyclin E/cdk2 kinase. (a) Cyclin E/cdk2 complexes were isolated by immuneprecipitation with anti-human cyclin E antibodies (`cE') from Sf9 insect cells that had been co-infected with baculoviruses expressing both cyclin E and cdk2. As control, either no antibody (`7') or an anti-c-abl antibody (`con') was used as indicated. Isolated complexes were incubated either with histone H1 or with the indicated concentration of p27 or both. (b) Phosphorylation of p27 occurs mainly at threonine 187. The indicated proteins were expressed as histidine-tagged proteins in E. coli and puri®ed by anity chromatography. They were incubated at the indicated concentrations with cyclin E/cdk2 complexes isolated from baculovirusinfected cells. (c) Western blot of 40 ng of each puri®ed p27 protein. p27D is more unstable in E. coli and runs aberrantly on a SDS gel
To assess how inhibition of p27 degradation aects induction of cyclin E/cdk2 kinase by Myc, cyclin E/ cdk2 kinase activity was determined from lysates of RAT1-MycER cells. Addition of PSI did not block induction of cyclin E/cdk2 kinase by Myc (Figure 2b ). PSI somewhat stabilized cyclin E protein: thus, we estimate that there is about a twofold decrease in the speci®c activity of cyclin E/cdk2 kinase if Myc is activated in the presence of PSI compared to control (induced) cells. Similarly, addition of PSI did not block the Myc-induced upregulation of human cyclin E/cdk2 kinase activity in RAT1-MycER (hcE) cells ( Figure  2c ). Immune-precipitations revealed that there was twofold less human cyclin E and cdk2 associated with p27, but unaltered amounts of human cyclin E/cdk2 complexes in lysates from 4-OHT/PSI treated relative to uninduced cells (Figure 2c) . Also, the increased amount of cyclin A present in induced relative to uninduced control cells was not associated with p27, even if degradation of p27 was blocked by addition of PSI ( Figure 2d ). Thus, degradation of p27 is not absolutely required for Myc-induced dissociation of p27/cyclin E/cdk2 and of p27/cyclin A/cdk2 complexes and for activation of cyclin E/cdk2 kinase activity. Taken together, our data show that activation of cyclin E/cdk2 complexes by MycER in resting cells occurs by a mechanism that is similar to the sequestration of p27 observed in Myc-transformed cells infected with recombinant retroviruses that ectopically express elevated levels of p27 (Vlach et al., 1996) .
Several time course experiments revealed that activation of cyclin E/cdk2 often preceded the loss of p27 from total cell extracts (data not shown). We wondered, therefore, whether there might be a preferential loss of p27 from cdk2 complexes at early time points after induction of Myc and prepared lysates from con¯uent RAT1-MycER cells before and at several time points after induction of Myc. From these lysates, we determined in parallel cyclin E/cdk2 kinase activity (Figure 3a ) and the amount of p27 complexed either with cyclin D1, cyclin D3 and with cdk2 and cyclin A (Figure 3b and c) . Similar to observations reported before, activation of Myc rapidly induced cyclin E/cdk2 kinase activity. There was an almost complete disappearance of p27 from cdk2 (Figure 3b and c) and from cyclin A (Figure 3c ) complexes at a time point at which there was no detectable decrease in the total amount of p27 and the amount of p27 complexed with either cyclin D1 or cyclin D3 (Figure 3b ). There was a twofold increase in the amount of endogenous cyclin E, but no increase in the amount of cyclin E/p27 complexes after induction of Myc, suggesting that a subset of cyclin E complexes had lost p27 upon activation of Myc (Figure 3c ). We concluded that at early time points, Myc-induced dissociation of p27 was speci®c for p27 bound to cdk complexes.
This observation prompted us to perform two experiments. First, we tested whether cyclin E/cdk2 complexes isolated from Myc-induced cells were resistant to inhibition by recombinant p27. We found that recombinant p27 inhibited cyclin E/cdk2 kinase activity from Myc-induced cells with an inhibition constant of 2.6+0.1 nM and of 4.1+0.25 nM for complexes isolated from non-induced cells (at 50 mM ATP; data not shown). Thus, activation of Myc does not render cyclin E/cdk2 complexes resistant to inhibition by p27.
Next we wondered whether p27 bound to cdk2 diered physically from p27 associated with D-type cyclin/cdk complexes. p27 has previously been shown to resolve into a number of discrete spots with dierent isoelectric points upon 2D gel electrophoresis (Celis et al., 1995) . In lysates from RAT1-MycER cells, p27 resolved into four major spots (labelled 1 to 4 in Figure  4a ). Treatment of cell lysates with phosphatase revealed that forms 2-4 were due to dierential phosphorylation of p27 (Figure 4a) .
From lysates of RAT1-MycER cells, we were able to visualize total p27 and p27 bound to cyclin D1. In contrast to the total cellular p27, anti-cyclin D1 immune-precipitates contained only spot 1 and a small amount of spot 2, but lacked the more acidic forms 3 and 4 (not shown). Control precipitations showed that cyclin D1 was associated with cdk4 under these conditions, precluding the possibility that lack of phosphorylation was due to the lack of a kinase subunit in the complex. We were unable to identify p27 in cyclin E, cyclin A or cdk2 complexes due to the To obtain a complete set of data, we exploited our observation that embryonic (E13) mouse brain expresses high levels of p27. This tissue expressed high levels of cyclin D2, but not cyclin D3 or cyclin D1 as judged by Western blotting. Total cell lysates showed a pattern of phosphorylated forms of p27 identical to RAT1-MycER cells upon 2D gel-electrophoresis (Figure 4b ). Lysates were prepared, immuneprecipitated with speci®c antibodies directed against cdk2, cyclin D2, cyclin A, and cyclin E and separated by 2D gel electrophoresis; as a control, total cell lysate was subjected to the same procedure (Figure 4b ). The two most basic forms of p27 (spots 1 and 2) were found in immune-precipitates with anti-cdk2-, cyclin D2-, cyclin A-and cyclin E-antibodies. The two most acidic phosphorylated forms of p27 (spots 3 and 4) were found only in association with cyclin E and A and with cdk2, but not in anti-cyclin D2 immuneprecipitates. The data show that p27 bound to cyclin E and cyclin A/cdk2 complexes diers from p27 bound to D-type cyclins as it is phosphorylated at at least one additional position. Thus, either cdk2 phosphorylates p27 directly or p27 bound to cdk2 is subject to phosphorylation by another kinase.
To determine whether cdk2 can phosphorylate p27 directly, we co-infected Sf9 cells with baculoviruses that express human cyclin E and cdk2. After infection, lysates were prepared and immune-precipitated with an anti-cyclin E antibody. Immune-precipitates were incubated with increasing concentrations of recombinant p27 (Figure 5a ). Phosphorylation of p27 was observed at 50 and 500 nM ®nal concentration of p27. Phosphorylation of both histone H1 and of p27 was observed when both proteins were mixed. Assuming that the protein-G sepharose is saturated with cyclin E/ cdk2 complexes, we estimate that these reactions contain an amount of cdk2 equivalent to 100 nM final concentration; this may provide an explanation as to why little inhibition of histone H1 phosphorylation is observed under the experimental conditions. To control whether either the immune-precipitates or the preparation of recombinant p27 were contaminated with another kinase, identical amounts of Sf9 lysates were immune-precipitated with an irrelevant antibody: no phosphorylation of either p27 or histone H1 was observed in these reactions (`con'). Finally, incubation of either puri®ed p27 or histone H1 without insect cell lysate did not yield phosphorylated protein. We concluded that p27 is both an inhibitor and a substrate for cyclin E/cdk2 kinase.
To determine which amino acid of p27 was phosphorylated by cdk2 in vitro, we expressed as histidine-tagged proteins and puri®ed p27 proteins that carry mutations at amino acids 187 (T187V and T187E) and at amino acid 10 (S10A) as well as a protein in which the last 15 amino acids were deleted (p27D). Equivalent amounts of each puri®ed protein (see Figure 5e ) were incubated with cyclin E/cdk2 kinase immune-precipitated from infected cells and the degree of phosphorylation determined. We observed that the p27T187V and p27T187E protein incorporated 75% less phosphate than either the wild-type p27 or p27S10A; no signi®cant phosphorylation of the truncated protein was found (Figure 5b ). We concluded that p27 is predominantly phosphorylated by cyclin E/cdk2 at threonine 187; the remaining phosphorylation occurs most likely at serine 183 (which is lost from p27D but present in the other mutants). Phosphorylation of p27 by cyclin E/cdk2 was observed even when phosphorylation of histone H1 was partially inhibited (see Figure 5a ). To con®rm this observation, increasing amounts of p27 were added to an in vitro kinase assay containing histone H1 as substrate. In these reactions, p27 phosphorylation by cyclin E/cdk2 was not inhibited even at a concentration of p27 that inhibited phosphorylation of histone H1 by more than 95% (Figure 6a and b) . Similar results were obtained both in the presence of 4 mM and 50 mM ATP ®nal concentration, although the total amount of p27 that was phosphorylated was lower at 50 mM ATP. We concluded that p27 does not signi®cantly inhibit its own phosphorylation by cyclin E/cdk2 kinase. In these reactions, we also observed phosphorylation of the cyclin E protein (Figure 5a) . From a reaction that contains neither histone H1 nor p27, the amount of phosphorylated cyclin E can be used as an internal standard for the amount of active cyclin E/cdk2 complexes present in the reaction. Assuming that both p27 (this report) and cyclin E (Clurman et al., 1996; Won and Reed, 1996) are phosphorylated by cdk2 at a single residue, we calculate from the radioactivity incorporated into cyclin E and p27 that up to three molecules of p27 are phosphorylated in the presence of 4 mM ATP per active cyclin E/cdk2 complex in multiple independent reactions. We conclude that turnover of p27 occurs in these reactions. Inhibition of histone H1 phosphorylation by p27 thus appears to result from competition for access to cyclin E/cdk2 rather than from inhibition of the catalytic activity of cdk2 itself.
To determine whether phosphorylated p27 diers in its interaction with cyclin E/cdk2 complexes from nonphosphorylated p27, increasing amounts of either wild Figure 7 In vitro analysis of mutant p27 proteins (a) Inhibition of histone H1 kinase activity of cyclin E/cdk2 by recombinant p27 proteins. The indicated alleles of p27 were expressed as histidine-tagged proteins in E. coli and puri®ed by Ni-agarose chromatography. They were incubated at the indicated ®nal concentrations with cyclin E/cdk2 complexes isolated by immuneprecipitation from induced RAT1-MycER cells. The amounts of protein used are documented in Figure 5 . (b) Cyclin E/cdk2 complexes immune-precipitated from infected Sf9 cells were incubated with either recombinant p27wt or p27T187V proteins. The input lanes correspond to 10% of the loaded material. Cyclin E/cdk2 complexes were reisolated and subjected either to three rounds of washing in buer containing 0.1% NP40 (sample a). Alternatively, they were washed as above, followed by an incubation for 1 h at 378C and reisolation (sample b). Shown is a Western blot of the bound p27 proteins. (c) Stability of dierent alleles of p27. Shown is the percentage of input p27 bound to cyclin E/cdk2 after washing as described above for three dierent alleles of p27. (d) Phosphorylated p27 is preferentially released from cyclin E/cdk2 complexes. Recombinant p27 was incubated with cyclin E/cdk2 complexes isolated from baculovirus-infected Sf9 cells as described above. Bound and free p27 were separated by centrifugation, bound p27 was eluted by boiling in SDS and both bound and eluted p27 fractionated by gel ®ltration chromatography. The panels show Western blots of the peak fractions for cyclin E, cdk2 and p27 and an autoradiography of phosphorylated p27 type recombinant p27 or of p27S10A, p27T187V, p27T187E or p27D (not shown) mutant proteins were incubated with cyclin E/cdk2 complexes isolated from growing RAT1-MycER cells and the histone H1 kinase activity determined. We found that neither mutation at residues 187 or 10 nor truncation of the last ®fteen amino acids aected the amount of p27 needed for half-maximal inhibition of cyclin E/cdk2 in vitro (Figure 7a ), suggesting that alterations at amino acid 187 do not aect the inhibition constant of p27 for cyclin E/cdk2 complexes. This is supported by our observation that p27 isolated by heat-treatment from MycER cells induced with 4-OHT in the presence of PSI is fully capable of inhibiting cyclin E/cdk2 kinase (data not shown). We next tested whether mutation at threonine 187 aected the stability of a ternary cyclin E/cdk2/p27 complex. Therefore, we preincubated saturating amounts of either p27wt or p27T187V with cyclin E/cdk2 complexes immune-precipitated from baculovirus infected cells; the complexes were then either subjected to three rounds of washing in buer containing detergent to determine the amount of stably bound p27 (Figure 7b : sample designated`A'). Alternatively, complexes were reisolated and washed and then incubated for another hour at 308C before they were reisolated again (Figure 7b : sample designated`B'). The amount of stably bound p27 was determined by Western blotting. In these experiments, p27 wt and p27T187V diered signi®cantly from each other as binding of p27T187V to cyclin E/cdk2 was signi®cantly more stable than that of p27wt, suggesting that mutation at that site lowers the o-rate of p27 from preassembled cyclin E/cdk2 complexes. Deletion of the last 15 amino acids further enhanced the stability of ternary cyclin E/cdk2/p27 complexes, suggesting that the carboxy-terminus of p27 functions as a negative regulator of complex stability. A quantitation of the results is shown in Figure 7c . To show directly that phosphorylation of p27 by cyclin E/cdk2 enhances its dissociation from cdk complexes, a limiting amount of recombinant p27 was bound to cyclin E/cdk2 in vitro and incubated in the presence of g[ 32 P]ATP as before. After the incubation, p27 released from cyclin E/cdk2 was isolated by centrifugation and gel ®ltration on a G-50 column. Bound p27 was dissociated by boiling in SDS and similarly separated over a G-50 column. Western blots of the fractions recovered from the G-50 columns revealed that little cyclin E and no cdk2 leaked from the beads during the incubation (Figure 7d ). We observed that only a small fraction of total p27 was released from cyclin E/cdk2 during the incubation. Autoradiography of the same fractions showed that a much higher fraction of phosphorylated p27 was released from cyclin E/cdk2 complexes during the incubation. From a comparison of both blots, we estimate that there is an at least tenfold enrichment of phosphorylated p27 in the eluted fractions. The data provide direct evidence that phosphorylation of p27 by cyclin E/cdk2 facilitates its release from cyclin E/cdk2 complexes in vitro.
We speculated, therefore, that phosphorylation of p27 by cdk2 might stimulate its dissociation from cyclin E/cdk2 complexes in vivo upon activation of Myc. This hypothesis makes a number of testable predictions: First, both dissociation and degradation should depend on cdk2 kinase activity in vivo. Two experiments were set up to test this prediction. First, we tested whether a speci®c inhibitor of cdk2 kinase activity, roscovitine, interfered with Myc-induced loss of p27 from cyclin E/cdk2 complexes (Abraham et al., 1995; Vesely et al., 1994) . RAT1-MycER cells were induced either in the absence or presence of roscovitine. Lysates were prepared, immune-precipitated with antibodies directed against cdk2, the precipitates separated by SDS ± PAGE and probed with antibodies directed against p27. As observed before, loss of p27 from cdk2 complexes preceded the Myc-induced degradation of p27 by several hours in the absence of roscovitine (Figure 8a) . Loss of p27 from cdk2 complexes was observed in the absence of roscovitine, but was signi®cantly delayed in the presence of the cdk2 inhibitor (Figure 8a) . Control experiments established that roscovitine did not interfere with the ability of Myc to induce the expression of a direct target gene, prothymosin-a (not shown). Roscovitine also blocked the decrease in the total amount of p27 present in cell lysates observed at later time points (Figure 8a ), suggesting that cdk2 kinase activity is required both for Myc-induced dissociation of p27 and degradation.
To extend these results, expression plasmids encoding either dominant negative alleles of cdk2, of cdk4 or encoding the cdk inhibitors p16 and p21 were microinjected into quiescent RAT1-MycER cells. Cells were subsequently induced for twelve hours, ®xed and stained with antibodies directed against p27. Injection of empty expression vector did not aect Myc-induced degradation of p27 (data not shown). In contrast, expression of dominant negative alleles of cdk2 or of the cdk inhibitor, p21, abolished Myc-induced degradation of p27 (Figure 8b ). Ectopic expression of p16 or of dominant negative alleles of cdk4 also inhibited Myc-induced degradation of p27, most likely because p16 (but not dominant negative alleles of cdk2) inhibits transactivation by Myc (Haas et al., 1997) . Taken together, the data show that cdk2 kinase activity is required for both Myc-induced dissociation of p27 from cyclin E/cdk2 complexes and its subsequent degradation.
Second, one would predict that there should be an accumulation of phosphorylated p27 after induction of Myc. To test this prediction, we infected RAT1-MycER cells at low density with recombinant retroviruses that express either p27wt, p27T187V, p27T187E or p27S10A. Under these experimental conditions, endogenous p27 is not detectable. 4-OHT was added, cells were harvested at several time points and lysates probed with an antibody directed against p27; to visualize potential phosphorylated forms of the protein, SDS ± PAGE was run signi®cantly longer than usual.
In these experiments, we observed a slower migrating band that appeared seven hours after activation of Myc; treatment of boiled cell lysates with calf intestine phosphatase revealed that this band was due to phosphorylation of p27 (Figure 9a and b) . This band was observed in cells infected with viruses expressing either wild-type p27 or p27S10A, but not in cells infected with viruses expressing p27T187V and p27T187E (Figure 9a ). We concluded that there is a transient accumulation of p27 phosphorylated at residue 187 in vivo after induction of Myc.
Phosphorylation of p27 D Mu Èller et al
To determine whether phosphorylated p27 was bound to cdk2 under these conditions, cell lysates were precipitated with anti-cdk2 antibodies (Figure 9a ). We observed a transient initial increase in the amount of p27 bound to cdk2, re¯ecting an early increase in the total amount of p27; this probably re¯ects the ®nding that the retroviral LTR that drives expression of p27 is stimulated by activation of Myc (ME, unpublished). As observed for endogenous p27, ectopically expressed p27 is rapidly dissociated from cdk2 complexes after activation of Myc and phosphorylated p27 did not accumulate bound to cdk2. Parallel immune-precipitations also did not reveal an accumulation of p27 on cyclins D1 and D3 (not shown). Wild-type p27, p27T187E and p27S10A were rapidly lost from cdk2 complexes after induction of Myc; in contrast, binding of p27T187V to cdk2 was signi®cantly more extensive and it dissociated more slowly from cdk2 complexes, although the total level of expression was identical to that of p27T187E and p27S10A.
Western blots of total p27 from these cells revealed that wtp27 and p27S10A disappeared from total cell extracts at later time points, suggesting that they were being degraded; disappearance of p27T187V was, in contrast, signi®cantly delayed, whereas the total level of p27T187E were somewhat variable (Figure 9c ). These data provide direct biochemical evidence for the transient accumulation of phosphorylated p27 in a non-cdk2 bound form before its subsequent degradation upon induction of Myc. Second, the observation that p27T187V is retarded re¯ects its behaviour in vitro and suggests that phosphorylation at threonine 187 facilitates Myc-induced dissociation of p27 from cyclin E/cdk2 complexes in vivo.
To test whether these biochemical data correlated with the rate of proliferation of these cells, RAT1-MycER cells were infected with either empty vector or retroviruses expressing dierent mutant alleles of p27. Cells were seeded at low density and grown in nonoestrogen depleted medium. Under these conditions, the MycER protein is partially active due to the low amounts of oestrogen present in serum. We chose this protocol as it circumvents the high rate of Mycinduced apoptosis observed when 4-OHT is added for longer time periods. The cell number was determined at several days after plating. Control RAT1 cells were almost completely growth-arrested upon infection with virus expressing wild-type p27 ( Figure 9d) ; in contrast, RAT1-MycER cells grew in the presence of wild-type p27, albeit at a reduced rate compared to non infected cells (Figure 9d) . In several independent experiments we found that the growth rate of cells infected with the p27T187V virus was even slower than that of cells infected with viruses encoding either wild-type p27, p27S10A or p27T187E (Figure 9d) . Thus, mutation of threonine 187 to valine retards both Myc-induced dissociation from cyclin E/cdk2 complexes in vivo and retards Myc-dependent proliferation.
Discussion
Previous work had shown that induction of Myc results in a rapid upregulation of cyclin E/cdk2 kinase activity and had suggested that Myc triggers the activation of pre-existing cyclin E/cdk2 complexes (Steiner et al., 1995) . We now show that this activation is due to a dissociation of p27 from cdk2 complexes; this precedes the actual degradation of p27. Dissociation is speci®c, as cyclin D/cdk4 complexes are stable for an extended period of time after induction of Myc; this correlates with previous observations that there is a slow increase in cyclin D1-dependent kinase activity after induction of Myc (Steiner et al., 1995) . Myc-induced dissociation of p27 from cdk2 complexes is facilitated by a cdk2-dependent phosphorylation of p27 at threonine 187. This notion is supported by four lines of evidence: First p27 was found to be a substrate for cdk2 in vitro. Cdk2 phosphorylates p27 predominantly at threonine 187. In vivo, p27 bound to cyclins E and cyclin A is hyperphosphorylated; in contrast, p27 bound to cyclins D1 and D2 is largely hypophosphorylated. Second, cdk2 kinase activity is required for dissociation of p27 from cyclin E/cdk2 complexes and degradation of p27 after induction of Myc. Third, mutation of threonine 187 to valine stabilises ternary cyclin E/cdk2/p27 complexes in vitro and delays Myc-induced dissociation of p27 from cdk2 in vivo. Fourth, p27 phosphorylated at threonine 187 accumulates after induction of Myc in an non-cdk2 bound form. We suggest that the requirement for carboxy-terminal phosphorylation of p27 explains the speci®c dissociation of p27 from cyclin E/cdk2 complexes and the speci®c activation of cyclin E/cdk2 kinase activity that is observed after activation of Myc (Steiner et al., 1995) .
Mutation of threonine 187 to either valine or glutamate does not alter the inhibition constant by which p27 inhibits cyclin E/cdk2 complexes in vitro. Also, phosphorylated p27 binds to cyclin E/cdk2 complexes in vitro and binding is speci®c as it is competed by cold p27 (DM, unpublished) . This is consistent with our observation that phosphorylated p27 is associated with cdk2 complexes in vivo. However, phosphorylation at threonine 187 decreases the stability of ternary cyclin E/cdk2/p27 complexes upon repeated washing and reisolation, suggesting that mutation at this site aects the on-and o-rate of cyclin E/cdk2/p27 complexes. The data show that phosphorylation of p27 per se cannot be sucient to generate a pool of free cyclin E/cdk2 complexes in vivo. We suggest that Myc directs the synthesis of proteins that bind to and ultimately degrade p27 that is transiently released from cyclin E/cdk2 complexes upon phosphorylation (Figure 10 ). Indeed, direct Rudolph et al., 1996) resistant to growth inhibition by ectopic expression of p27 (Vlach et al., 1996) . What might the identity of these proteins be? There are several obvious parralels between Myc-induced dissociation of cyclin E/cdk2/p27 complexes and proteasome-dependent degradation of p27. First, activation of Myc induces both dissociation of p27 from cyclin E/ cdk2 complexes and its subsequent degradation. Second, both Myc-induced dissociation and degradation of p27 depend on cdk2 kinase activity. Finally, mutation of threonine 187 to valine delays Mycinduced dissociation of p27 from cyclin E/cdk2 complexes and inhibits degradation of p27 in proliferating cells (Shea et al., 1997) . It seems possible, therefore, that dissociation of p27 upon induction of Myc may re¯ect the ®rst step in degradation of p27. If degradation of p27 has similarities to the degradation of G1 cyclins in S. cerevisiae, our observations may be equivalent to the recognition of phosphorylated Cln2 by a Cdc53/Cdc34/Cdc4 complex which precedes its degradation (e.g. Bai et al., 1996; Lanker et al., 1996; Willems et al., 1996) . In this sense, the Myc-dependent sequestration' of p27 reported by Amati and colleagues may refer to the formation of a similar complex (Vlach et al., 1996) . However, we have no evidence that p27 accumulating after induction of Myc is ubiquitinated. Thus, the precise relationship between the proteasome-dependent degradation of p27 and the dissociation observed after induction of Myc remains to be determined. If most or all cyclin E/cdk2 is bound to p27 in resting cells, how can Myc induce dissociation of p27 from these complexes? As one solution, it has been suggested that the moderate activation of cyclin E expression by Myc (Jansen-DuÈ rr et al., 1993) might trigger the synthesis of a small amount of free and active cyclin E/cdk2 complexes which then start a positive feedback-loop that phosphorylates and releases p27 from pre-existing ternary complexes (Perez-Roger et al., 1997) . This model assumes that either p27 bound to one cyclin E/cdk2 complex can be phosphorylated by a second cyclin E/cdk2 complex or that the on-and o rates for p27 to cyclin E/cdk2 are high enough to allow a few active complexes to phosphorylate multiple p27 molecules in vivo.
A tacit assumption in this model is that a cyclin E/ cdk2 complex with a bound molecule of p27 is inactive as a kinase towards p27. Our data are not easily compatible with this assumption: we ®nd that cyclin E/ cdk2 complexes actively phosphorylate p27 even when their kinase activity towards histone H1 is inhibited by more than 95%. Assuming that the protein Gsepharose is saturated by cyclin E/cdk2 complexes, the molar excess of p27 relative to cyclin E/cdk2 is approximately eightfold at a concentration of 750 nM p27. Thus, if p27 phosphorylation by cyclin E/cdk2 required the presence of one p27-free complex, a strong inhibition should occur. This is not observed. Further, if phsophorylation of cyclin E is taken as a measure for the amount of active cyclin E/cdk2 complexes, we calculate that up to three molecules of p27 are phosphorylated per cyclin E/cdk2 complex present in these reactions. Thus, multiple rounds of p27 phosphorylation occur per cyclin E/cdk2 complex without apparent inhibition by p27; again, the lack of inhibition under these conditions is hard to reconcile with a model that requires the presence of p27-free complexes for phosphorylation of p27 and strongly favours a model in which p27 is phosphorylated by a single cyclin E/cdk2 complex. Therefore, the potential function of a positive feedback loop is somewhat unclear. The ®ndings also alleviate the need to invoke a transient complex in which p27 associates with cyclin E, but not cdk2 as suggested by Amati and colleagues (Vlach et al., 1997, in press ). Alternatively, phosphorylation and degradation of p27 might be increased in response to elevated levels of cdc25A protein that is induced by Myc (Galaktionov et al., 1996) . Indeed, our data show that cdk2 activity is required for Myc to act upon p27. The ®nding that cdc25A activity remains rate-limiting for full activation of cyclin E/cdk2 complexes after activation of Myc (Steiner et al., 1995) does not argue against such a view, assuming that there is some turnover even of non-phosphorylated p27 that allows a small number of active cdk2 complexes to phosphorylate a large number of p27 molecules in vivo.
At present, there appear to be three ®ndings that are not explained by the hypothesis that Myc acts upstream of cdc25A expression to induce cyclin E/ cdk2 kinase activity: ®rst, induction of cyclin E/cdk2 kinase activity in RAT1-MycER cells occurs without signi®cant changes in the amount of cdc25A protein (Perez-Roger et al., 1997; Pusch et al., 1997; Vlach et al., 1996) . Second, phosphorylation of p27 does not appear to aect its anity to cyclin E/cdk2 complexes in vitro, yet p27 dissociates from cyclin E/cdk2 complexes and is degraded in vivo upon activation of Myc. Third, cdc25A cannot substitute for Myc in the activation of cyclin E/cdk2 kinase activity, whereas protein that bind to and sequester p27 can overcome a G1 arrest imposed by dominant negative alleles of Myc (Berns et al., 1997) .
Resting RAT1-MycER cells contain signi®cant amounts of cyclin E, cdk2 and of cdc25A proteins; taken together with data reported in this paper, this strongly suggests that phosphorylation of p27 by cyclin E/cdk2 occurs constitutively in these cells and that phosphorylation of exogenous substrates is blocked due to steric hindrance by p27. By far the simplest model describing the regulation of cyclin E/cdk2 kinase in RAT1-MycER cells is one in which phosphorylation of p27 by cyclin E/cdk2 does not depend on Myc function; phosphorylation by cyclin E/cdk2 enhances the on-and o-rate from complexes whereas p27 bound to D-type cyclin complexes is non-phosphorylated and more stable. Activation of Myc induces the synthesis of proteins that bind to and ultimately degrade p27 that is released from cyclin E/cdk2 complexes upon phosphorylation (Figure 10 ). This model makes the testable prediction that the ability of a cell to sequester and degrade p27 should require Myc function independently of the requirement for cyclin E/cdk2 to phosphorylate p27.
Materials and methods

Tissue culture and microinjection experiments
All experiments were carried out in RAT1-MycER (Eilers et al., 1989) or RAT1-MycER 2 (Littlewood et al., 1995) cells as indicated. Cells were cultured as described previously (Steiner et al., 1995) . Brie¯y, cells were grown to con¯uence and then refed every two days for a period of 4 ± 6 days before addition of 4-hydroxy-tamoxifen (4-OHT) to a ®nal concentration of 200 nM. Microinjections were carried out as described (Rudolph et al., 1996) . To generate RAT1-MycER(hcE) cells, RAT1-MycER cells were transfected with a pBabe-Puro vector (Morgenstern and Land, 1990 ) carrying a full length human cyclin E cDNA (kind gift of Rolf MuÈ ller). Resistant cells were selected in medium containing 2.5 mg/ml puromycin and 200 mg/ml neomycin and pooled. Mutant alleles of p27 cloned in pBabe-Puro were a kind gift of J Vlach and B Amati. Retroviruses were generated by transient transfection of BOSC23 cells (Pear et al., 1993) . PSI (Cbz-IleGlu(otBu)Ala-Leucinal) and ICE Inhibitor I (Ac-Tyr-Val-AlaAspartic acid aldehyde; Bachem) were used at a ®nal concentration of 50 mM each. Roscovitine was used as described (Rudolph et al., 1996) .
Preparation of telencephalic vesicles
E13 mouse embryos were prepared according to (Copp and Cockroft, 1990) . Telencephalic vesicles were dissected in ice-cold PBS and immediately frozen in liquid nitrogen. Between one and ®fteen telencephalic vesicles were pooled and extracts prepared in NP-40 lysis buer containing both protease and phosphatase inhibitors (Steiner et al., 1995) . 
IEF 2D-Gel electrophoresis
Immune-precipitations were carried out and washed in NP-40 lysis buer as described before (Steiner et al., 1995) . Protein-G sepharose beads were frozen and thawed in O'Farrell lysis buer (O'Farrell, 1975) . IEF-2D-Gel electrophoresis was carried out according to (O'Farrell, 1975) except that the following mixture of ampholytes (Pharmacia) was used: pH 3.5 ± 9.5: 3.5% (v/v); pH 5 ± 7: 1.75% (v/v); pH 7 ± 9: 1.75% (v/v). 12%-PAGE was used as the second dimension. Western blots were carried out using an enhanced chemoluminescence protocol according to the manufacturer's instructions (Amersham); where indicated, a¯uoroimager was used for detection. For phosphatase treatment, 100 mg cell lysate was boiled to remove the bulk of cellular protein and clari®ed by centrifugation. Control experiments showed that boiling did not aect the pattern of spots seen in the 2D gels (data not shown). Clari®ed lysates were incubated with 100 units of calf intestine phosphatase (CIP) for 30 min at 8C according to the manufacturer's instructions (Boehringer).
Cyclin E/cdk2 kinase assays
Cyclin E/cdk2 kinase assays using histone H1 as substrate were carried out as described previously (Steiner et al., 1995) ; to analyse human cyclin E kinase activity, we used a commercial antibody (HE-111; Santa Cruz). As control, an anti-mad-1 antibody was used (Santa Cruz). To detect phosphorylation of p27, Sf9 insect cells were co-infected with baculoviruses expressing cyclin E and cdk2 (Gu et al., 1993) . Lysates were prepared and precipitated with either anti-cyclin E or anti c-abl (Santa Cruz) antibodies; as control 0.5 mg of antibody was used in each reaction with saturating amounts of protein-G sepharose and cell lysate. Incubations were carried out in a ®nal volume of 20 ml containing the indicated ®nal concentration of p27 and of ATP and 2 ± 5 mCi [ 32 P]ATP. 1.25 mg histone H1 was added where indicated.
Recombinant p27 protein was puri®ed by denaturing Nianity chromatography according to the manufacturer's instructions (Quiagen) and used to raise a polyclonal antiserum in rabbits. Depletion and immunecomplex kinase experiments were carried out using both this antiserum and a commercial antibody raised against the 19 carboxy-terminal amino acids (C-19; Santa Cruz). For depletion experiments, 200 mg of total cell lysate was incubated for 1 min at 1008C, clari®ed by centrifugation and incubated with 5 ml C-19 or 20 ml polyclonal antiserum prebound to 20 ml Protein-G sepharose. Two rounds of depletion were performed, one for four hours and the subsequent one overnight. Inhibition constants were determined from Lineweaver-Burk diagrams.
Antibodies
Anti-p27 Western blots and immune¯uorescence experiments were performed with a monoclonal antibody (Signal Transduction Laboratories). Cyclin D2 was detected with monoclonal antibody DCS-3, cyclin D3 with monoclonal antibody DCS-22; both were generous gifts from Jiri Bartek. Other antibodies were used as described (Rudolph et al., 1996) .
